BP1223, a Novel T Cell Engager Targeting CD39 for Potent Antitumor Activity in Acute Myeloid Leukemia

被引：0
|
作者：
Yuda, Junichiro [1 ]
Aramaki, Takahiko [2 ]
Matsumura, Haruka [2 ]
Nakajima, Kanto [2 ]
Mie, Motoya [2 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Expt Therapeut, Kashiwa, Japan
[2] BrightPath Biotherapeut Co Ltd, Kawasaki Res Labs, Kawasaki, Japan
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-200048
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4146 / 4147
页数：2
相关论文
共 50 条
  • [41] A novel immunoliposome mediated by CD123 antibody targeting to acute myeloid leukemia cells
    Wang, Yin
    Liu, Furong
    Wang, Qiantao
    Xiang, Honglin
    Jin, Hui
    Li, Hui
    Mao, Shengjun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 529 (1-2) : 531 - 542
  • [42] Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile
    Zeng, Zhihong
    Roobrouck, Annelies
    Deschamps, Geert
    Bonnevaux, Helene
    Guerif, Stephane
    De Brabandere, Veronique
    Amara, Celine
    Dejonckheere, Eline
    Virone-Oddos, Angela
    Chiron, Marielle
    Konopleva, Marina
    Dullaers, Melissa
    BLOOD ADVANCES, 2024, 8 (09) : 2059 - 2073
  • [43] Bispecific T cell engager-armed T cells targeting integrin αvβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma
    Suwanchiwasiri, Kwanpirom
    Phanthaphol, Nattaporn
    Somboonpatarakun, Chalermchai
    Yuti, Pornpimon
    Sujjitjoon, Jatuporn
    Luangwattananun, Piriya
    Maher, John
    Yenchitsomanus, Pa-thai
    Junking, Mutita
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [44] Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success
    Michelozzi, Ilaria M.
    Kirtsios, Efstratios
    Giustacchini, Alice
    CANCERS, 2021, 13 (11)
  • [45] Optimized CD70-Targeted CAR Secreting a CD33-Targeted Bispecific T-cell Engager Overcomes Antigen Heterogeneity for Acute Myeloid Leukemia
    Leick, Mark
    Silva, Harrison
    Martin, Grace
    Kann, Michael
    Wehrli, Marc
    Choi, Bryan
    Kuo, Adam
    Larson, Rebecca
    Schmidts, Andrea
    Bailey, Stefanie
    Grauwet, Korneel
    Bouffard, Amanda
    Gallagher, Kathleen
    Elder, Eva
    Katsis, Katelin
    Grazewski, Kirsten
    Maus, Marcela
    MOLECULAR THERAPY, 2022, 30 (04) : 576 - 577
  • [46] Preparation of a novel tri-specific T cell engager targeting CD19 antigen and its anti-leukemia effect exploration
    陈曼玲
    China Medical Abstracts(Internal Medicine), 2021, 38 (03) : 185 - 185
  • [47] Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
    Wiernik, Andres
    Foley, Bree
    Zhang, Bin
    Verneris, Michael R.
    Warlick, Erica
    Gleason, Michelle K.
    Ross, Julie A.
    Luo, Xianghua
    Weisdorf, Daniel J.
    Walcheck, Bruce
    Vallera, Daniel A.
    Miller, Jeffrey S.
    CLINICAL CANCER RESEARCH, 2013, 19 (14) : 3844 - 3855
  • [48] Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
    Isabelle Laverdière
    Meaghan Boileau
    Andrea L. Neumann
    Héloïse Frison
    Amanda Mitchell
    Stanley W. K. Ng
    Jean C. Y. Wang
    Mark D. Minden
    Kolja Eppert
    Blood Cancer Journal, 8
  • [49] Development of a Novel Cell Therapy Targeting SSX2 for Acute Myeloid Leukemia
    Achour, Achouak A.
    MOLECULAR THERAPY, 2024, 32 (04) : 830 - 830
  • [50] Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
    Laverdiere, Isabelle
    Boileau, Meaghan
    Neumann, Andrea L.
    Frison, Heloise
    Mitchell, Amanda
    Ng, Stanley W. K.
    Wang, Jean C. Y.
    Minden, Mark D.
    Eppert, Kolja
    BLOOD CANCER JOURNAL, 2018, 8
12345